Cargando…
Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
We report on a 63-year-old man with a history of hepatitis B virus–related hepatocellular carcinoma with a thrombus extending into the inferior vena cava, who received image-guided stereotactic body radiation therapy (SBRT) with helical tomotherapy, followed by sorafenib. A total tumor dose of 48 Gy...
Autores principales: | Hsieh, Chen-Hsi, Lin, Shih-Chiang, Shueng, Pei-Wei, Kuo, Deng-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069149/ https://www.ncbi.nlm.nih.gov/pubmed/24971021 http://dx.doi.org/10.2147/OTT.S64706 |
Ejemplares similares
-
Radiation Recall Dermatitis in Patients Treated with Sorafenib
por: Mehta, Keyur, et al.
Publicado: (2018) -
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
por: Kim, Gwi Eon, et al.
Publicado: (2017) -
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
por: Oh, Dongryul, et al.
Publicado: (2013) -
Case report: Stereotactic body radiation therapy with 12 Gy for silencing refractory ventricular tachycardia
por: Huang, Shan-Hui, et al.
Publicado: (2022) -
Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy
por: Sweren, Evan, et al.
Publicado: (2021)